GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,705.00p
   
  • Change Today:
      32.00p
  • 52 Week High: 1,718.50p
  • 52 Week Low: 1,316.00p
  • Currency: UK Pounds
  • Shares Issued: 4,144.92m
  • Volume: 5,851,351
  • Market Cap: £70,671m
  • RiskGrade: 129

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 24,696.00 3,599.00 90.56p 22.2 n/a -22% 80.00p 4.0%
31-Dec-22 29,324.00 5,628.00 139.70p 10.3 0.2 +54% 44.00p 3.1%
31-Mar-23 6,951.00 1,907.00 150.06p 9.5 1.4 +7% 56.78p 4.0%
31-Dec-23 30,328.00 6,064.00 155.10p 9.4 3.1 +3% 42.00p 2.9%
31-Mar-24 7,363.00 1,355.00 43.10p 39.6 n/a -72% 15.00p 0.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 31,553.33 8,741.48 156.70p 10.9 0.0 +264% 60.72p 0.0%
31-Dec-25 33,491.67 9,681.07 175.33p 9.7 0.8 +12% 64.64p 0.0%
31-Dec-26 35,263.09 10,734.87 194.09p 8.8 0.8 +11% 68.74p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 22.18 9.35 18.20 2.17

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

GSK Market Data

Currency UK Pounds
Share Price 1,705.00p
Change Today 32.00p
% Change 1.91 %
52 Week High 1,718.50p
52 Week Low 1,316.00p
Volume 5,851,351
Shares Issued 4,144.92m
Market Cap £70,671m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.82% below the market average71.82% below the market average71.82% below the market average71.82% below the market average71.82% below the market average
72% below the sector average72% below the sector average72% below the sector average72% below the sector average72% below the sector average
Price Trend
45.88% above the market average45.88% above the market average45.88% above the market average45.88% above the market average45.88% above the market average
67.27% above the sector average67.27% above the sector average67.27% above the sector average67.27% above the sector average67.27% above the sector average
Income
18.09% below the market average18.09% below the market average18.09% below the market average18.09% below the market average18.09% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
96.45% below the market average96.45% below the market average96.45% below the market average96.45% below the market average96.45% below the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 01-May-2024

Time Volume / Share Price
15:54 0 @ 1,701.50p
15:47 1 @ 1,700.50p
15:51 0 @ 1,701.50p
15:51 0 @ 1,701.50p
15:51 0 @ 1,701.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page